GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market ...

Blenrep, which is predicted by analysts to produce revenues of around $1.5bn in 2026, is an antibody-drug conjugate that works by targeting B-cell maturation antigen (BCMA), a protein commonly ...

A new mineral discovered recently in an abandoned gold mine in Hungary has been named kanatzidisite in honor of Greek scientist Mercouri Kanatzidis, an inorganic chemist at Northwestern University, ...

Upon a potential return to the White House, Donald Trump has outlined a series of immediate actions for his first day and second term. These include dismissing legal cases against him, enacting ...

Teva Pharmaceutical Industries Ltd. ADR-2.23% $19.91B ...

101 years ago today, one of the most famous dogs in the world, Hachikō the Akita, was born in Ōdate. He is beloved, revered, ...

Nov. 8, 2024 — Researchers today are releasing the flagship dataset from an ambitious study of biomarkers and environmental factors that might influence the development of type 2 diabetes ...

Nov. 7, 2024 — Plastic pollution exacerbates the impacts of all planetary boundaries, including climate change, ocean acidification and biodiversity loss, a new paper shows. Ahead of the final ...

Centurion Samson blasts 10 sixes as India beat South Africa in opening T20 All our updates as India beat South Africa in Durban in the opening match of their four-match T20 series.

CENTRAL GOVERNMENT FUNDS: Social welfare would account for the largest portion of the NT$3.33 trillion budget, followed by spending on education, tech and culture ...

“强大的创新管线布局和行动力，都让我看到了GSK对中国市场的重视和未来发展的潜力。”作为一名生物医药领域的资深从业者，张宁于2024年加入GSK中国管理团队，成为公司特药业务部负责人，他的选择正是基于对公司战略布局的认同和对未来发展的期待。